1. Carnitine palmitoyl-transferase 1A is potentially involved in bovine herpesvirus 1 productive infection.
- Author
-
Yang, Hao, Gu, Wenyuan, Ni, Junqing, Ma, Yabin, Li, Shitao, Neumann, Donna, Ding, Xiuyan, and Zhu, Liqian
- Subjects
- *
CARNITINE , *BOS , *VIRAL proteins , *GLUTATHIONE transferase , *PROTEIN expression , *ENERGY consumption - Abstract
Bovine herpesvirus 1(BoHV-1) is an important bovine pathogen that causes great economic loss to cattle farms worldwide. The virus-productive infection in bovine kidney (MDBK) cells results in ATP depletion. The mechanisms are not well understood. Mitochondrial fatty acid β-oxidation (FAO) is an important energy source in many tissues with high energy demand. Since carnitine palmitoyl-transferase 1 A (CPT1A) is the rate-limiting enzyme of FAO, we investigated the interactions between virus-productive infection and CPT1A signaling. Here, we found that virus-productive infection at the later stage significantly decreased CPT1A protein levels in all the detected cells, including MDBK, A549, and Neuro-2A cells, differentially altered the accumulation of CPT1A proteins in the nucleus and cytosol, and re-localized the protein in the nucleus. Etomoxir (ETO), an irreversible inhibitor of CPT1A, inhibited viral replication and partially interfered with the ability of BoHV-1 to alter CPT1A accumulation in the nucleus but not in the cytosol. Furthermore, ETO consistently reduced RNA levels of two viral regulatory proteins (bICP0 and bICP22) and protein expression of virion-associated proteins during productive infection, further supporting the important roles of CPT1A signaling in BoHV-1 productive infection. These data, for the first time, suggest that CPT1A is potentially involved in BoHV-1 productive infection. • BoHV-1 productive infection has effects on CPT1A protein expression and subcellular localization. • CPT1A signaling plays an important role in BoHV-1 productive infection. • BoHV-1 infection-induced nuclear accumulation of CPT1A was iterupted by CPT1A-specific inhibitor Etomoxir. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF